Latest Apolipoprotein E Stories
A team of scientists, led by Western University of Health Sciences Professor Doug Ethell, PhD, has developed a blood test for Alzheimer’s disease risk that may lead to earlier detection and
Two drugs to be studied in North America and Europe in volunteers at high risk for disease COPENHAGEN, Denmark, July 15, 2014 /PRNewswire/ -- Researchers from the Banner Alzheimer's
A genetic variant conveys significant protection MONTREAL, July 15 2014 /CNW Telbec/ - Judes Poirier, PhD, C.Q., from the Douglas Mental Health Institute and McGill University
OSAKA, Japan and DURHAM, N.C., July 10, 2014 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") and its partner, Zinfandel Pharmaceuticals, Inc.
Maintaining hippocampus volume is key to delaying cognitive decline and onset of dementia symptoms in those with genetic risk for Alzheimer's
New research from scientists at Stanford University has revealed a genetic variant that raises the risk of developing Alzheimer’s disease in women, but not in men.
The Jeffrey Epstein VI Foundation backs a critical study that advances Alzheimer's as the 3rd leading cause of death in the United States. NEW YORK, March 24, 2014 /PRNewswire/ --
A new study reveals that a blood test has been discovered and validated that can predict if a healthy person will develop mild cognitive impairment or Alzheimer's disease within three years.
For over 40 years scientists have recognized that DDT, a synthetic pesticide, harms bird habitats and is threatening to the environment. Although DDT was banned in the United States in 1972, other countries continue to use it as a pesticide.
The presence of a gene variant in people with mild cognitive impairment (MCI) is associated with accelerated rates of brain atrophy, according to a new study published online in the journal Radiology.
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.